I. Thorup, HISTOMORPHOLOGICAL AND IMMUNOHISTOCHEMICAL CHARACTERIZATION OF COLONIC ABERRANT CRYPT FOCI IN RATS - RELATIONSHIP TO GROWTH-FACTOR EXPRESSION, Carcinogenesis, 18(3), 1997, pp. 465-472
Many studies have been conducted to assess the potential preneoplastic
nature of colonic aberrant crypt foci (ACF), but still the biological
significance of these foci and their relationship to colon neoplasia
remains to be elucidated, In the present paper a battery of variables
suggested to be indicative for colon cancer development has been studi
ed in relation to ACF in rats, These include: (i) the degree of dyspla
sia; (ii) the type of mucus production; (iii) the cellular immunohisto
chemical expression and distribution of transforming growth factors al
pha and beta and their respective receptors, epidermal growth factor r
eceptor and transforming growth factor beta receptors I and II and pho
sphorylated cellular tyrosine, The parameters have been investigated i
n ACF selected from a previous study where the foci were induced under
different circumstances, leading to disparities in the number as well
as the crypt multiplicity obtained, The present study showed that for
all parameters investigated, apart from sialomucin production, the di
fferent experimental conditions had no effect on the individual ACF, i
rrespective of the number and distribution of the different categories
of ACF among the various diets, However, it was shown that the degree
of dysplasia correlated strongly with crypt multiplicity and that all
the investigated ACF lacked expression of transforming growth factor
alpha and expressed a reduced amount of transforming growth factor bet
a compared with normal crypts, These observations may indicate that AC
F are preneoplastic lesions and supports the suggestion that they may,
at least in the rat, have the potential to gradually progress to tumo
rs, but no single ACF showed particular characteristics indicating spe
cific proneness to tumor development, The study could not confirm the
presence of sialomucin-producing ACF as a valid marker for tumor devel
opment.